Fidelity International
BOLD

Fidelity International’s Audentes Therapeutics, Inc BOLD Stock Holding History

Fidelity International’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-208,922
Closed -$12.5M – 1066
2019
Q4 		$12.5M Buy
+208,922
New +$7.84M 0.02% 471

Fidelity International's BOLD Position: Q1 2020 in Review

Fidelity International sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 208,922 shares — an estimated $12.5M sold.

Fidelity International first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $12.5M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Fidelity International reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Fidelity International sold 208,922 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $12.5M.
  • Fidelity International first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Fidelity International's Audentes Therapeutics, Inc position peaked at $12.5M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Fidelity International's 13F filing for Q1 2020, filed 14 May 2020.